Navegar por término CIE "Enfermedad mieloproliferativa crónica"

Mostrando ítems 1-8 de 8

Clinical characteristics, prognosis and treatment of myelofibrosis patients with severe thrombocytopenia

2018- Hernández-Boluda, Juan Carlos; Correa, Juan-Gonzalo; Álvarez-Larrán, Alberto; Ferrer-Marín, Francisca; Raya, José-María; [et al.]
Essential thrombocythaemia with mutation in MPL: clinicopathological correlation and comparison with JAK2V617F-mutated and CALR-mutated genotypes

2018- Álvarez-Larrán, Alberto; Martínez, Daniel; Arenillas, Leonor; Rubio, Ariadna; Arellano-Rodrigo, Eduardo; [et al.]
Familial Myeloproliferative Syndrome

1994- Pérez Encinas, Manuel Mateo; Bello López, José Luis; Pérez Crespo, Susana; De Miguel, R.; Tome, S. [et al.]
Impact of somatic gene mutations on the risk of thrombosis in myelofibrosis

2024-11- Pastor-Galán, Irene; Pereira, Arturo; Arellano-Rodrigo, Eduardo; Martín, Iván; Mosquera Orgueira, Adrián; [et al.]
Performance of the myelofibrosis secondary to PV and ET-prognostic model (MYSEC-PM) in a series of 262 patients from the Spanish registry of myelofibrosis

2018- Hernández-Boluda, Juan Carlos; Pereira, Arturo; Correa, Juan-Gonzalo; Álvarez-Larrán, Alberto; Ferrer-Marín, Francisca; [et al.]
Predictive factors for anemia response to erythropoiesis-stimulating agents in myelofibrosis

2017- Hernández-Boluda, Juan Carlos; Correa, Juan-Gonzalo; García-Delgado, Regina; Martínez López, Joaquín; Álvarez-Larrán, Alberto; [et al.]
Prognostic risk models for transplant decision-making in myelofibrosis

2018- Hernández-Boluda, Juan Carlos; Pereira, Arturo; Correa, Juan-Gonzalo; Álvarez-Larrán, Alberto; Ferrer-Marín, Francisca; [et al.]
Second cancers in MPN: Survival analysis from an international study

2020-03- Marchetti, Monia; Ghirardi, Arianna; Masciulli, Arianna; Carobbio, Alessandra; Palandri, Francesca; [et al.]